Novartis | Kortsiktig Gjeld

Current Liabilities Endring Dato
AbbVie USD 34.77B 2.53B 2023-09
Almirall EUR 271.92M 2.69M 2023-06
Amgen USD 18.39B 1.44B 2023-12
AstraZeneca USD 28.59B 2.21B 2023-09
Bayer EUR 33.08B 894M 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Galapagos EUR 444.04M 31.04M 2023-09
Genmab DKK 2.9B 909M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
GlaxoSmithKline GBP 22.39B 282M 2023-09
GRIFOLS EUR 2.32B 290.54M 2023-12
Hikma Pharmaceutical USD 1.22B 138M 2023-06
Lonza CHF 2.71B 369M 2023-06
Pfizer USD 31.14B 3.51B 2023-09
Recordati EUR 955.64M 5.48M 2023-09
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Roche Holding CHF 26.21B 1.03B 2023-06
UCB EUR 2.65B 464M 2023-06



Novartis Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.